Laboratory for Health Protection Research, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Crit Rev Toxicol. 2010 May;40(5):389-404. doi: 10.3109/10408440903524262.
Predictive tests to identify the sensitizing properties of chemicals are carried out using animals. In the European Union timelines for phasing out many standard animal tests were established for cosmetics. Following this policy, the new European Chemicals Legislation (REACH) favors alternative methods, if validated and appropriate. In this review the authors aim to provide a state-of-the art overview of alternative methods (in silico, in chemico, and in vitro) to identify contact and respiratory sensitizing capacity and in some occasions give a measure of potency. The past few years have seen major advances in QSAR (quantitative structure-activity relationship) models where especially mechanism-based models have great potential, peptide reactivity assays where multiple parameters can be measured simultaneously, providing a more complete reactivity profile, and cell-based assays. Several cell-based assays are in development, not only using different cell types, but also several specifically developed assays such as three-dimenionally (3D)-reconstituted skin models, an antioxidant response reporter assay, determination of signaling pathways, and gene profiling. Some of these assays show relatively high sensitivity and specificity for a large number of sensitizers and should enter validation (or are indeed entering this process). Integrating multiple assays in a decision tree or integrated testing system is a next step, but has yet to be developed. Adequate risk assessment, however, is likely to require significantly more time and efforts.
用于识别化学品致敏特性的预测性测试是在动物身上进行的。在欧盟,为化妆品制定了淘汰许多标准动物测试的时间表。根据这一政策,新的欧洲化学品法规 (REACH) 倾向于替代方法,如果经过验证和适当的话。在这篇综述中,作者旨在提供替代方法(计算、化学和体外)的最新概述,以确定接触和呼吸致敏能力,并在某些情况下提供效力的衡量标准。在过去的几年中,QSAR(定量构效关系)模型取得了重大进展,特别是基于机制的模型具有巨大的潜力,肽反应性测定法可以同时测量多个参数,提供更完整的反应性谱,以及基于细胞的测定法。正在开发几种基于细胞的测定法,不仅使用不同的细胞类型,而且还使用几种专门开发的测定法,如三维(3D)重建皮肤模型、抗氧化反应报告测定法、信号通路的测定和基因谱分析。其中一些测定法对大量致敏剂具有相对较高的敏感性和特异性,应该进入验证(或实际上正在进入这一过程)。将多个测定法整合到决策树或综合测试系统中是下一步,但尚未开发出来。然而,充分的风险评估可能需要更多的时间和努力。